| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 6 | +83.33% | -3.30% | +1.98% | -5.28% | -6.14% | — |
| 14d | 6 | +66.67% | -0.97% | +1.86% | -2.83% | -3.86% | — |
| 30d | 6 | +66.67% | -2.95% | +6.20% | -9.15% | -5.19% | — |
| 60d | 6 | +66.67% | -2.41% | +8.76% | -12.11% | -12.83% | — |
| 90d | 6 | +33.33% | +3.69% | +11.71% | -8.03% | -2.10% | — |
| 180d | 6(1 pending) | +40.00% | +21.96% | +16.93% | +5.02% | +11.49% | — |
| 1y | 6(3 pending) | +0.00% | +53.93% | +28.18% | +25.75% | +8.14% | — |
| 2y | 6(6 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| OKUR ONKURE THERAPEUTICS, INC. | SALE Chief Financial Officer | 303 | $4.40 | $1.3K | 18,802 | Jun 22, 2026 | Jun 24, 2026 ↗ | View → |
| OKUR ONKURE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 110,000 | — | — | 110,000 | Apr 1, 2026 | Apr 3, 2026 ↗ | View → |
| OKUR ONKURE THERAPEUTICS, INC. | SALE Chief Financial Officer | 301 | $4.16 | $1.3K | 16,000 | Mar 23, 2026 | Mar 24, 2026 ↗ | View → |
| OKUR ONKURE THERAPEUTICS, INC. | SALE Chief Financial Officer | 302 | $2.97 | $896 | 16,301 | Dec 22, 2025 | Dec 23, 2025 ↗ | View → |
| OKUR ONKURE THERAPEUTICS, INC. | SALE Chief Financial Officer | 303 | $2.62 | $795 | 12,603 | Sep 22, 2025 | Sep 24, 2025 ↗ | View → |
| OKUR ONKURE THERAPEUTICS, INC. | SALE Chief Financial Officer | 303 | $2.38 | $722 | 12,906 | Jun 23, 2025 | Jun 25, 2025 ↗ | View → |
| OKUR ONKURE THERAPEUTICS, INC. | SALE Chief Financial Officer | 1,844 | $2.67 | $4.9K | 13,209 | Apr 7, 2025 | Apr 8, 2025 ↗ | View → |
| OKUR ONKURE THERAPEUTICS, INC. | SALE Chief Financial Officer | 1,278 | $3.33 | $4.3K | 15,053 | Apr 4, 2025 | Apr 8, 2025 ↗ | View → |
| OKUR ONKURE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 65,000 | — | — | 65,000 | Jan 27, 2025 | Jan 29, 2025 ↗ | View → |
| OKUR ONKURE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 16,331 | — | — | 16,331 | Oct 4, 2024 | Oct 8, 2024 ↗ | View → |
| OKUR ONKURE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 5,781 | — | — | 5,781 | Oct 4, 2024 | Oct 8, 2024 ↗ | View → |
| OKUR ONKURE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 5,322 | — | — | 5,322 | Oct 4, 2024 | Oct 8, 2024 ↗ | View → |
| OKUR ONKURE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 130,611 | — | — | 130,611 | Oct 4, 2024 | Oct 8, 2024 ↗ | View → |
| VRDN VIRIDIAN THERAPEUTICS, INC.DE | PURCHASEGRANT Stock grant | 311,785 | — | — | 311,785 | Jan 18, 2021 | Jan 20, 2021 ↗ | View → |